Xenotransplantation of the liver

Clinics in Liver Disease

Volumn 4, Issue 3, 2000, Pages 731-746

  Kanai, Nobuyuki ^a   Platt, Jeffrey L ^a,b,c  

^a Department of Surgery ^*  (United States)

^b Immunology   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; INFECTIOUS COMPLICATION; LIVER FAILURE; LIVER TRANSPLANTATION; MEDICAL RESEARCH; METABOLIC DISORDER; NONHUMAN; POSTOPERATIVE COMPLICATION; REVIEW; TREATMENT INDICATION; XENOTRANSPLANTATION;

EID: 0033885464     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70135-5     Document Type: Article

References (75)

1. G.M. Abouna P.K. Gangoly H.M. Hamdy Extracorporeal liver perfusion system for successful hepatic support pending liver regeneration or liver transplantation: A pre–clinical controlled trial Transplantation 67 1999 1576 1583
2. G.M. Abouna J.R. Kirkley C.J. Hull Treatment of hepatic coma by extracorporeal pig-liver perfusion Lancet 1 1969 64 68
3. J.S. Allan Xenotransplantation at a crossroads: Prevention versus progress Nat Med 2 1996 18 21
4. F.H. Bach W.W. Hancock C. Ferran Protective genes expressed in endothelial cells: A regulatory response to injury Immunol Today 18 1997 483 486
5. F.H. Bach H. Winkler C. Ferran Delayed xenograft rejection Immunol Today 17 1996 379 384
6. A.D. Bannett R.F. McAlack M. Morris ABO incompatible renal transplantation: A qualitative analysis of native endothelial tissue ABO antigens after transplant Transpl Proc 21 1989 783 785
7. H. Bismuth J. Figueiro D. Samuel What should we expect from a bioartificial liver in fulminant hepatic failure? Artif Organs 22 1998 26 31
8. G.W. Byrne K.R. McCurry M.J. Martin Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage Transplantation 63 1997 149 155
9. R.Y. Calne D.R. Davis J.R. Pena Hepatic allografts and xenografts in primates Lancet 1 1970 103 106
10. R.S. Chari B.H. Collins J.C. Magee Brief report: Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation N Engl J Med 331 1994 234 237
11. S.C. Chen C. Mullon E. Kahaku Treatment of severe liver failure with a bioartificial liver Ann N Y Acad Sci 831 1997 350 360
12. M.W. Chopek R.L. Simmons J.L. Platt ABO-incompatible renal transplantation: initial immunopathologic evaluation Transpl Proc 19 1987 4553 4557
13. B.H. Collins R.S. Chari J.C. Magee Mechanisms of injury in porcine livers perfused with blood of humans with fulminant hepatic failure Transplantation 58 1994 1162 1171
14. E. Cozzi N. Yannoutsos G.A. Langford Effect of transgenic expression of human decay-accelerating factor on the inhibition of hyperacute rejection of pig organs D.K.C. Cooper E. Kemp J.L. Platt Xenotransplantation: the transplantation of organs and tissues between species 1997 Springer Berlin 665 682
15. C.W. Daggett M. Yeatman A.J. Lodge Total respiratory support from swine lungs in primate recipients J Thorac Cardiovas Surg 115 1998 19 27
16. A.P. Dalmasso G.M. Vercellotti J.L. Platt Inhibition of complement-mediated endothelial cell cytotoxicity by decay accelerating factor: Potential for prevention of xenograft hyperacute rejection Transplantation 52 1991 530 533
17. T. Deacon J. Schumacher J. Dinsmore Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease Nat Med 3 1997 350 353
18. M. Desille L. Corcos A. L'Helgoualc'h Detoxifying activity in pig livers and hepatocytes intended for xenotherapy Transplantation 68 1999 1437 1443
19. A.S.B. Edge M.E. Gosse J. Dinsmore Xenogeneic cell therapy: Current progress and future developments in porcine cell transplantation Cell Transplant 7 1998 525 539
20. J. Edwards Complement activation by xenogeneic red blood cells Transplantation 31 1981 226 227
21. I. Fox J. Chowdhury S. Kaufman Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation N Engl J Med 338 1998 1422 1426
22. J. Fung A. Rao D. Phil Clinical trials and projected future of liver xenotransplantation World J Surg 21 1997 956 961
23. U. Galili M.R. Clark S.B. Shohet Evolutionary relationship between the natural anti-Gal antibody and the Gal α1-3Gal epitope in primates Proc Natl Acad Sci USA 84 1987 1369 1373
24. R.L. Geller P. Rubinstein J.L. Platt Variation in expression of porcine xenogeneic antigens Transplantation 58 1994 272 277
25. G.R. Giles H.J. Boehmig H. Amemiya Clinical heterotransplantation of the liver Transpl Proc 2 1970 506 512
26. J. Gugenheim D. Samuel M. Reynes Liver transplantation across ABO blood group barriers Lancet 336 1990 519 523
27. A.M. Harper J.D. Rosendale M.A. McBride The UNOS OPTN waiting list and donor registry Clin Transpl 3 1998 73 90
28. Holzknecht ZE, Coombes S, Blocher BA, et al. Evidence of immunocomplex formation in pulmonary xenografts. Transpl Proc, in press
29. C.W. Hoopes J.L. Platt Hepatocyte transplantation: History, immunology, and potential for clinical application Biotech Lab International 3 1998 11 14
30. S.T. Ildstad M.S. Vacchio P.M. Markus Cross-species transplantation tolerance: Rat bone marrow-derived cells can contribute to the ligand for negative selection of mouse T cell receptor Vβ in chimeras tolerant to xenogeneic antigens (mouse + rat → mouse) J Exp Med 175 1992 147 155
31. L. Inverardi M. Samaja R. Motterlini Early recognition of a discordant xenogeneic organ by human circulating lymphocytes J Immunol 149 1992 1416 1423
32. A. Jain J. Reyes R. Kashyap What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients Ann Surg 230 1999 441 449
33. D.A. Kelly D. Mayer Liver transplantation [chapter 17] D.A. Kelly Diseases of the Liver and Biliary System in Children 1999 Blackwell Science Oxford 293 312
34. S.J. Knechtle P.C. Kolbeck S. Tsuchimoto Hepatic transplantation into sensitized recipients: demonstration of hyperacute rejection Transplantation 43 1987 8 12
35. J. Lake Hepatocyte transplantation N Engl J Med 338 1998 1463 1465
36. J.H. Lawson L. Daniels J.L. Platt The evaluation of thrombomodulin activity in porcine to human xenotransplantation Transplant Proc 29 1997 884 885
37. J.H. Lawson J.L. Platt Molecular barriers to xenotransplantation Transplantation 62 1996 303 310
38. Lawson JH, Platt JL. Xenotransplantation: prospects for clinical application. In: Owen W, Pereira B, M S. (eds). Dialysis and transplantation: a companion to Brenner and Rector's The Kidney. Philadelphia, WB Saunders, in press
39. J.R. Leventhal A.P. Dalmasso J.W. Cromwell Prolongation of cardiac xenograft survival by depletion of complement Transplantation 55 1993 857 866
40. J.R. Leventhal A.J. Matas L.H. Sun The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model Transplantation 56 1993 1 8
41. S.S. Lin D.L. Kooyman L.J. Daniels The role of natural anti-Galα1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants Transpl Immunol 5 1997 212 218
42. S.S. Lin B.C. Weidner G.W. Byrne The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants J Clin Invest 101 1998 1745 1756
43. J.S. Logan M.J. Martin Transgenic swine as a recombinant production system for human hemoglobin Methods Enzymol 231 1994 435 445
44. J.C. Magee B.H. Collins R.C. Harland Immunoglobulin prevents complement mediated hyperacute rejection in swine-to-primate xenotransplantation J Clin Invest 96 1995 2404 2412
45. L. Makowka D.V. Cramer A. Hoffman The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure Transplantation 59 12 1995 1654 1659
46. K.R. McCurry D.L. Kooyman C.G. Alvarado Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury Nat Med 1 1995 423 427
47. R.M. Merion L.M. Colletti Hyperacute rejection in porcine liver transplantation: I. Clinical characteristics, histopathology, and disappearance of donor-specific lymphocytotoxic antibody from serum Transplantation 49 1990 861 868
48. K. Paradis G. Langford Z. Long Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue Science 285 1999 1236 1241
49. W. Parker S. Saadi S.S. Lin Transplantation of discordant xenografts: a challenge revisited Immunol Today 17 1996 373 378
50. C. Patience G.S. Patton Y. Takeuchi No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys Lancet 352 1998 699 701
51. C. Patience Y. Takeuchi R.A. Weiss Infection of human cells by an endogenous retrovirus of pigs Nat Med 3 1997 282 286
52. S.P. Pereira R. Williams Limits to liver transplantation in the UK Gut 42 1998 883 885
53. Platt J “Xenoassistance devices” for the treatment of hepatic failure: challenges and controversies. Transpl Proc, in press
54. J.L. Platt Genetic therapies in xenotransplantation Expert Opinion in Investigational Drugs 8 1999 1653 1662
55. J.L. Platt Hyperacute Xenograft Rejection 1994 CRC Press Austin
56. J.L. Platt R.J. Fischel A.J. Matas Immunopathology of hyperacute xenograft rejection in a swine-to-primate model Transplantation 52 1991 214 220
57. J.L. Platt S.S. Lin C.G.A. McGregor Acute vascular rejection Xenotransplantation 5 1998 169 175
58. J.L. Platt G.M. Vercellotti A.P. Dalmasso Transplantation of discordant xenografts: A review of progress Immunol Today 11 1990 450 456
59. K.A. Porter Renal Transplantation R.H. Heptinstall Pathology of the Kidney vol 3 1992 Little, Brown, & Co Boston, MA 1799 1933
60. S.K. Pruitt A.D. Kirk R.R. Bollinger The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts Transplantation 57 1994 363 370
61. K. Reemtsma B.H. McCracken J.U. Schlegel Renal heterotransplantation in man Ann Surg 160 1964 384 410
62. M. Rela P. Muiesan H. Vilca-Melendez Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I Ann Surg 229 1999 565 569
63. H. Rosen C. Shackeleton P. Martin Indications for and timing of liver transplantation P. Martin L. Friedman The Medical Clinics of North America: Management of Chronic Liver Disease vol 80 1996 WB Saunders Philadelphia 1069 1102
64. D.H. Sachs T. Sablinski Tolerance across discordant xenogeneic barriers Xenotransplantation 2 1995 234 239
65. M.S. Sandrin W.L. Fodor E. Mouhtouris Enzymatic remodelling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody binding and complement-mediated cytolysis Nat Med 1 1995 1261 1267
66. T.E. Starzl Liver transplantation Gastroenterology 112 1997 288 291
67. T.E. Starzl A.J. Demetris N. Murase Cell migration, chimerism, and graft acceptance Lancet 339 1992 1579 1582
68. T.E. Starzl J. Fung A. Tzakis Baboon-to-human liver transplantation Lancet 341 1993 65 71
69. T.E. Starzl C.W. Putnam K.A. Porter Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction Transpl Proc 6 1974 129 139
70. T.E. Starzl A. Tzakis J.J. Fung Prospects of clinical xenotransplantation Transpl Proc 26 1994 1082 1088
71. S. Taniguchi D.K.C. Cooper Clinical xenotransplantation–a brief review of the world experience D.K.C. Cooper E. Kemp J.L. Platt Xenotransplantation 1997 Springer-Verlag Berlin 776 784
72. A.D. Thall P. Malý J.B. Lowe Oocyte Galα1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse The J Biol Chem 270 1995 21437 21440
73. X. Wang R. Andersson Hepatocyte transplantation: a potential treatment for acute liver failure Scand J Gastroenterol 30 1995 193 200
74. F.D. Watanabe C.J. Mullon W.R. Hewitt Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial Ann Surg 225 1997 484 491
75. Y. Zhao K. Swenson J.J. Sergio Skin graft tolerance across a discordant xenogeneic barrier Nat Med 2 1996 1211 1216